[Active chronic hepatitis caused by the B virus (ACH-B). Recent pathogenetic acquisitions and elements of serological, clinical and histopathological diagnosis].
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D006509:Hepatitis B / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D006510:Hepatitis B Antibodies / Q000032:analysis; D006514:Hepatitis B Surface Antigens / Q000032:analysis / Q000276:immunology; D006513:Hepatitis B e Antigens / Q000276:immunology; D006515:Hepatitis B virus / Q000648:ultrastructure; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D007372:Interferons / Q000627:therapeutic use; D007978:Levamisole / Q000627:therapeutic use; D008099:Liver / Q000473:pathology; D009336:Necrosis; D014165:Transfer Factor / Q000627:therapeutic use; D014779:Virus Replication
D000893:Anti-Inflammatory Agents; D000998:Antiviral Agents; D006510:Hepatitis B Antibodies; D006514:Hepatitis B Surface Antigens; D006513:Hepatitis B e Antigens; D007136:Immunoglobulins; D014165:Transfer Factor; D007978:Levamisole; D007372:Interferons
L'epatite cronica attiva da virus B (ECA-B). Recenti acquisizioni patogenetiche ed elementi di diagnostica sierologica, clinica ed istopatologica.